Podcasts about patient access

In this episode, Niklas Anzinger sits down with Stephen Martin, U.S. Lead at Infinita and Operations Lead of the Montana Experimental Treatment Review Board (ETRB), to explore what could become a new model for biotech development and patient access in the United States.Montana SB 535, is a new framework allowing eligible post-Phase 1 experimental treatments to reach patients under regulated oversight with special clinic licenses and an expert review board. Stephen explains why traditional Right-to-Try and expanded access programs have struggled to scale, and how Montana could change the economics by allowing biotechs to generate real-world evidence, treat patients, and create revenue earlier in the development process.They discuss how the pathway works in practice, who qualifies, opportunities for biotech companies and physicians, the relationship between state and federal regulation, the FDA's role, and whether Montana could ultimately provide a blueprint for accelerating drug development across the United States.More on this topic:* Scott Alexander on the Aduhelm Approval* Jared Rhoads on X This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.infinitacitytimes.com

What if the biggest threat to your healthcare organization isn't competition or reimbursement rates — it's the moment one of your team members decided that the policy was more important than the person in front of them? In this episode, Jamie sits down with Matt Staub, CEO of Your Health, to explore the timeless "Give 'Em the Pickle" philosophy — born in a burger joint, but almost perfectly designed for healthcare. Matt and Jamie unpack the four pillars of the pickle framework — service, attitude, consistency, and teamwork — and trace each one directly into the reality of patient care, care team dynamics, and organizational culture. Video LinkGive Em The Pickle Youtube Video   What you'll hear in this episode: Why charging a loyal customer 75 cents for extra pickles is the same mistake healthcare makes every day — and how the Ritz Carlton's $2,500 employee empowerment policy points to a better way How attitude isn't just a soft skill — it's the infrastructure of every patient interaction, including the ones where you're already having a bad day Why mistakes in healthcare aren't failures — they're invitations, and the patients who complained and felt heard often become your fiercest advocates What real consistency looks like in care delivery: not doing the same thing robotically, but doing ordinary things extraordinarily well, every single time How teamwork in healthcare means every person in the organization — from the CEO to the community health worker — has a role in whether the patient feels seen and served This episode will challenge you to look at service not as a department or a satisfaction score, but as the very soul of what your organization stands for. Give 'em the pickle.

In this episode, Jennifer Venator, MSN, RN, CNS, CNOR, CRNFA, Executive Director, Surgical Services, Providence St. Jude Medical Center in Fullerton CA, shares how trusted, real-time data is improving surgical access, operational efficiency, and collaboration across care teams. She also discusses how automation and emerging AI capabilities can streamline perioperative workflows, reduce administrative burden, and help clinicians stay focused on patient care.

Dr. Erin Palm, medical lead at Infinitus, specializes in agentic AI for healthcare, leveraging voice technology to facilitate actions and execute tasks on behalf of providers, payers, and patients to coordinate administrative functions and patient-facing applications. These agents can handle appointment booking, medication inquiries, and emergency triage within an environment with rigorous quality controls and guardrails to mitigate  AI errors. The platform supports seven languages, adapts communication to technical levels, and integrates with patient systems to maintain clinical consistency and regulatory compliance. Erin explains, "We focus on agentic communications for healthcare, which means building AI agents that can have conversations and execute on tasks on behalf of patients, pharmaceutical manufacturers, providers, and health plans. And our thesis in all this is that the care exists. It's the coordination layer that sometimes falls short and fails patients, and Infinitus makes sure that that care arrives."   "It's a reality that we're holding AI to a different standard than we hold humans performing the same tasks. That said, I actually see it as an opportunity to improve quality across the board. And I think it's reasonable to hold AI to a higher standard. And we measure those things closely using continuous evaluations of agent performance even before we put them into production. And then once they're live with patients, we continue to closely monitor their performance."  "We have benchmarks that show improved performance on tasks versus human agents doing some of those same tasks, such as appointment booking. That said, we know that generative AI DRs make mistakes and it predicts things that don't end up being true. And we call those hallucinations. In the clinical world, we like to call them confabulations. It tends to be more clinically correct." #Infinitus #AIinHealthcare #VoiceAI #DigitalHealth #HealthIT #PriorAuth #PatientAccess #HealthcareInnovation #AgenticAI #PatientSafety #HealthcareAutomation infinitus.ai Download the transcript here

Dr. Erin Palm, medical lead at Infinitus, specializes in agentic AI for healthcare, leveraging voice technology to facilitate actions and execute tasks on behalf of providers, payers, and patients to coordinate administrative functions and patient-facing applications. These agents can handle appointment booking, medication inquiries, and emergency triage within an environment with rigorous quality controls and guardrails to mitigate  AI errors. The platform supports seven languages, adapts communication to technical levels, and integrates with patient systems to maintain clinical consistency and regulatory compliance. Erin explains, "We focus on agentic communications for healthcare, which means building AI agents that can have conversations and execute on tasks on behalf of patients, pharmaceutical manufacturers, providers, and health plans. And our thesis in all this is that the care exists. It's the coordination layer that sometimes falls short and fails patients, and Infinitus makes sure that that care arrives."   "It's a reality that we're holding AI to a different standard than we hold humans performing the same tasks. That said, I actually see it as an opportunity to improve quality across the board. And I think it's reasonable to hold AI to a higher standard. And we measure those things closely using continuous evaluations of agent performance even before we put them into production. And then once they're live with patients, we continue to closely monitor their performance."  "We have benchmarks that show improved performance on tasks versus human agents doing some of those same tasks, such as appointment booking. That said, we know that generative AI DRs make mistakes and it predicts things that don't end up being true. And we call those hallucinations. In the clinical world, we like to call them confabulations. It tends to be more clinically correct." #Infinitus #AIinHealthcare #VoiceAI #DigitalHealth #HealthIT #PriorAuth #PatientAccess #HealthcareInnovation #AgenticAI #PatientSafety #HealthcareAutomation infinitus.ai Listen to the podcast here

Healthy Lifestyle 8-1-26 Kelly Laurel - Minutes to Heal, Months to Wait - How one CEO is Rewriting Patient Access to Surgery by JVC Broadcasting

For episode 260 of the Crypto Altruists podcast, we're excited to welcome Sharonda D., a registered nurse with 20 years at the bedside, a tech builder, and a member of the crypto community. She's helping launch the Crypto Community Fund for Healthcare Access in partnership with Sostento, a nonprofit dedicated to helping uninsured Americans reach the care they need.I want to take you back to 2021. PPE had run out. Everywhere. And nurses and health workers showed up to their shifts anyway, putting themselves at risk because that's what the job asked of them. In the middle of all that, something remarkable happened. Sostento mobilized the crypto community, raised 25 ETH in a matter of weeks, and got real protective equipment into the hands of thousands of frontline workers.Sharonda was a nurse on the floor during that shortage. And now, years later, she's helping mobilize that same community for what comes next.Her story doesn't start with crypto. It starts on the floor. She became a nurse during the transition from paper charts to electronic health records, and she watched experienced nurses walk away from the profession because the technology simply wasn't built with them in mind. That stuck with her, and it's shaped everything she's done since. Today she's a division director with the Global Nursing AI Alliance, a builder of practical tools for nurses, and someone who has spent her career refusing to accept that technology should be something done to health workers rather than with them.In today's discussion you'll learn:

A rapid-fire segment highlighting positive developments in digital health. Janae and Megan share insights on recent innovations, successful implementations, and emerging trends that are driving progress in healthcare technology. Learn about cutting-edge solutions improving patient outcomes Discover how technology is enhancing healthcare accessibility Gain insight into successful digital health implementations Stay informed about positive industry trends shaping the future of care Janae Sharp, Founder, The Sharp Index Megan Antonelli, Chief Executive Officer, HealthIMPACT Live Subscribe to Digital Health Talks on Apple Podcasts, Spotify, YouTube, or wherever you listen. Learn more about HealthIMPACT Live events, virtual forums, and healthcare leader conversations at healthimpactlive.com. Interested in being a guest, sponsoring, or joining the HealthIMPACT community? Visit healthimpactlive.com/digital-health-talks. Subscribe to Digital Health Talks on Apple Podcasts, Spotify, YouTube, or wherever you listen.Learn more about HealthIMPACT Live events, virtual forums, and healthcare leader conversations at healthimpactlive.com.Interested in being a guest, sponsoring, or joining the HealthIMPACT community? Visit healthimpactlive.com/digital-health-talks.

In this episode of the Gladden Longevity podcast, Dr. Gladden interviews Shaun Noorian from Empower Pharmacy, discussing the growth and mission of the pharmacy, the cost-effectiveness of compounding medications, quality standards in compounding, regulatory oversight, and the ongoing controversy surrounding peptides and FDA decisions. The conversation highlights the importance of personalized medicine and the challenges faced by compounding pharmacies in providing affordable and effective treatments for patients. In this conversation, Dr. Gladden and Shaun Noorian discuss the evolving landscape of compounding pharmacies and personalized medicine. They explore the regulatory challenges faced by compounding pharmacies, the promise of new medications like retatrutide, and the role of GLP-1s in health management. The discussion highlights the importance of muscle preservation in weight loss therapies and the advocacy needed to ensure patient access to compounded medications. They emphasize the renaissance of compounding in healthcare, which is making treatments more accessible and affordable for patients.   For Audience Join the other 20,000+ high-performers getting weekly insights on biological reversal, exponential strategies, and Life Energy optimization→ https://start.gladdenlongevity.com/subscribe If you're ready to measure your 60+ biological ages and build a personalized reversal plan, apply for a discovery call here → https://start.gladdenlongevity.com/apply-now   Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/!     Takeaways ·       Empower Pharmacy has been operational for 17 years and focuses on personalized medicine. ·       Compounding pharmacies are becoming more popular due to their cost-effectiveness compared to commercial options. ·       Quality standards in compounding are well-established and continuously updated. ·       Compounding pharmacies are subject to rigorous regulatory oversight and inspections. ·       The FDA is currently reviewing the status of several peptides for compounding. ·       Recent changes in the FDA advisory committee may impact the approval of new compounds. ·       The conversation emphasizes the need for evidence-based decisions in healthcare. ·       Dr. Gladden highlights the discrepancies in drug approvals and their implications for patient care. ·       The black market for peptides poses significant risks to patient safety. ·       The discussion underscores the importance of maintaining high-quality standards in compounding pharmacies. The FDA's decisions will significantly impact compounding pharmacies. ·       Compounding pharmacies ensure medication integrity and safety. ·       Personalized medicine is expanding into various health areas. ·       Regulatory challenges hinder the compounding of certain medications. ·       Retatrutide is expected to revolutionize weight loss therapies. ·       GLP-1s have multiple health benefits beyond weight loss. ·       Weight loss therapies can lead to muscle loss, complicating health outcomes. ·       Innovative alternatives to GLP-1s are emerging in the market. ·       Compounding pharmacies play a crucial role in patient access to medications. ·       Advocacy against pharmaceutical monopolies is essential for patient care.    Chapters 00:00 Empower Pharmacy's Growth and Mission 03:01 Cost-Effectiveness of Compounding Pharmacies 06:00 Quality Standards in Compounding 08:54 Regulatory Oversight and Compliance 12:01 The Peptide Controversy 15:03 The Impact of FDA Decisions on Patient Care 18:21 The Future of Compounding Pharmacies 20:09 Expanding Areas of Personalized Medicine 21:11 Regulatory Challenges in Compounding 22:04 The Promise of Retatrutid 23:39 The Role of GLP-1s in Health 25:02 The Impact of Weight Loss Therapies 26:07 Innovative Alternatives to GLP-1s 27:10 The Importance of Muscle Preservation 28:31 The Role of Compounding Pharmacies in Patient Access 30:16 Advocacy Against Pharmaceutical Monopolies 32:20 Navigating Regulatory Landscapes 34:14 The Renaissance of Compounding in Healthcare   To learn more about Shaun Noorian:Email: media@Empowerpharmacy.com Website: https://www.empowerpharmacy.com/ Instagram: https://www.instagram.com/empowerpharmacy   Reach out to us at:    Website: https://gladdenlongevity.com/     Facebook: https://www.facebook.com/Gladdenlongevity/    Instagram: https://www.instagram.com/gladdenlongevity/?hl=en     LinkedIn: https://www.linkedin.com/company/gladdenlongevity    YouTube: https://www.youtube.com/channel/UC5_q8nexY4K5ilgFnKm7naw       Gladden Longevity Podcast Disclosures Production & Independence The Gladden Longevity Podcast and Age Hackers are produced by Gladden Longevity Podcast, which operates independently from Dr. Jeffrey Gladden's clinical practice and research at Gladden Longevity in Irving, Texas. Dr. Gladden may serve as a founder, advisor, or investor in select health, wellness, or longevity-related ventures. These may occasionally be referenced in podcast discussions when relevant to educational topics. Any such mentions are for informational purposes only and do not constitute endorsements. Medical Disclaimer The Gladden Longevity Podcast is intended for educational and informational purposes only. It does not constitute the practice of medicine, nursing, or other professional healthcare services — including the giving of medical advice — and no doctor–patient relationship is formed through this podcast or its associated content. The information shared on this podcast, including opinions, research discussions, and referenced materials, is not intended to replace or serve as a substitute for professional medical advice, diagnosis, or treatment. Listeners should not disregard or delay seeking medical advice for any condition they may have. Always seek the guidance of a qualified healthcare professional regarding any questions or concerns about your health, medical conditions, or treatment options. Use of information from this podcast and any linked materials is at the listener's own risk. Podcast Guest Disclosures Guests on the Gladden Longevity Podcast may hold financial interests, advisory roles, or ownership stakes in companies, products, or services discussed during their appearance. The views expressed by guests are their own and do not necessarily reflect the opinions or positions of Gladden Longevity, Dr. Jeffrey Gladden, or the production team. Sponsorships & Affiliate Disclosures To support the creation of high-quality educational content, the Gladden Longevity Podcast may include paid sponsorships or affiliate partnerships. Any such partnerships will be clearly identified during episodes or noted in the accompanying show notes. We may receive compensation through affiliate links or sponsorship agreements when products or services are mentioned on the show. However, these partnerships do not influence the opinions, recommendations, or clinical integrity of the information presented. Additional Note on Content Integrity All content is carefully curated to align with our mission of promoting science-based, ethical, and responsible approaches to health, wellness, and longevity. We strive to maintain the highest standards of transparency and educational value in all our communications.

For years, health systems have focused on building a strong digital front door. But what happens when patients begin their healthcare journey somewhere else entirely?In this episode of The All Access Pass Podcast, Elizabeth Woodcock sits down with Jordan Moore, MBA, Division Chair of the Enterprise Office of Access Management at Mayo Clinic, to explore how artificial intelligence is changing the way patients search for care, choose providers, and navigate the healthcare system.As more consumers turn to AI tools for guidance, health systems face a new challenge: ensuring they remain visible, accessible, and ready to meet patients wherever they begin their search. Jordan shares how Mayo Clinic is preparing for this shift—from rethinking decision trees and demand forecasting to exploring new approaches to patient-provider matching and capacity management.Together, they discuss what access leaders need to do now to prepare for a future where the patient journey starts before a website visit, phone call, or portal login.If you work in patient access, digital strategy, or ambulatory operations, this conversation offers practical insights into the technologies, expectations, and opportunities shaping the future of healthcare access.

The future of healthcare isn't just smarter agentic AI—it's better access. Hyro is transforming how patients connect with health systems through responsible AI that simplifies scheduling, streamlines support, and helps people get the care they need. In this episode, Hyro CEO and Co-Founder Israel Krush shares how AI agents are helping some of the nation's largest health systems modernize the patient experience. Driven by the belief that many of healthcare's biggest challenges can be solved through responsible AI, Hyro has focused on improving what Israel describes as one of the most critical interactions in healthcare: the connection between patients and the health system. From automating appointment scheduling and call center operations to closing care gaps and improving engagement, Hyro is driving measurable results while keeping care human-centered. As Israel explains, "We want to transform healthcare. We want to disrupt healthcare. We don't want to own healthcare." Israel also discusses what it takes to scale agentic AI in healthcare, why responsible guardrails matter, and how organizations can move from experimentation to real-world impact. Along the way, he shares lessons on leadership, innovation, digital transformation, and building technology that solves meaningful healthcare challenges. Tune in to learn how AI agents are reshaping access to care and creating better experiences for patients, providers, and health systems alike.

Automation is changing patient access, but prior authorization still requires more than bots, portals, and percentage-based promises. On this episode, Lindsey Nelson, Product Marketing Director at Infinx, explores why agentic workflows, human expertise, clinical judgment, and operational visibility all matter when organizations are trying to reduce delays, avoid denials, and keep work moving. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Credentialing rarely makes headlines, but it plays a critical role in determining how quickly patients can access care, how providers join health plan networks, and how healthcare organizations maintain quality at scale. In this episode of Quality Matters, host Tsveta Polhemus examines why credentialing has become one of the most important foundations for modern healthcare delivery—especially as virtual care continues expanding across states and specialties. Joining the conversation are Sharon Meers, President and Co-Founder of Midi Health, and Greg Smith, Director of Operations at Evernorth Health Services. Together, they explore how credentialing impacts providers, payers, and patients alike, and why standardized, trusted processes are essential for improving access while maintaining confidence in care. Sharon shares Midi Health's remarkable growth from approximately 20 clinicians to nearly 800 providers serving patients nationwide. As the organization rapidly expanded across all 50 states, credentialing and payer enrollment became one of its greatest operational challenges. She explains how achieving NCQA Credentialing Accreditation enabled delegated credentialing with major national payers, reducing enrollment timelines from months to just days and allowing patients to access care sooner. Greg offers the payer perspective, discussing how credentialing supports network adequacy, strengthens audit readiness, and creates greater consistency across provider networks. He explains why recognized standards help reduce administrative friction while giving health plans greater confidence in the organizations they partner with. The episode concludes with a Patient Voice segment featuring Carroll Schreibman, who shares her experience navigating perimenopause symptoms after years of searching for answers. She reflects on how quickly accessing virtual care through Midi Health transformed her health, work, and quality of life—and why listening to patients remains central to delivering meaningful care. As healthcare delivery continues evolving, one message becomes clear: credentialing isn't simply a compliance exercise. It's the infrastructure that enables trusted, timely, and equitable access to quality care. Highlights Credentialing Enables Access Credentialing determines how quickly providers can begin seeing patients, making it one of the most important drivers of timely access to care. Scaling Virtual Care Responsibly Midi Health shares how standardized credentialing supported rapid national expansion while maintaining consistency and quality. Trusted Standards Build Confidence NCQA Credentialing Accreditation creates a common framework that strengthens relationships between providers, payers, and patients. The Payer Perspective Credentialing helps health plans improve network adequacy, streamline oversight, and reduce administrative burden while supporting quality care. A Patient's Experience Carroll Schreibman shares how timely virtual access to menopause care helped restore her quality of life after years of unanswered questions.     Key Quote "Credentialing isn't just a compliance requirement—it's the infrastructure that makes timely, trusted, high-quality care possible." — Sharon Meers     Time Stamps - Waiting on Final File (00:00) Why Credentialing Matters More Than Ever (01:52) Meet Sharon Meers & Greg Smith (05:43) A Patient's Journey to Virtual Care (09:25) Credentialing 101: Why It Matters (12:12) How Delegated Credentialing Improves Access (14:36) Scaling Midi Health from 20 to 800 Clinicians (18:00) Balancing Speed, Quality, and Trust (24:44) Measuring Patient Access and Outcomes (28:47) The Future of Credentialing and Virtual Care (33:25) Patient Voice: Carroll Schreibman's Story (42:47) Key Takeaways and Closing Thoughts     Links & Resources NCQA Credentialing Accreditation Learn more about Midi Health Learn more about Evernorth Health Services Connect with Sharon Meers Connect with Greg Smith Connect with Carroll Schreibman Connect with Tsveta Polhemus Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

What happens when life-saving medications exist, but patients still can't access them?In this episode of Success Leaves Clues, Robin Bailey and Al McDonald sit down with John Leombruno, CEO of OkRx, healthcare entrepreneur, pharmacist, and former founder of Patient Direct Pharmacy and GMD Distribution, to explore one of healthcare's biggest hidden challenges: helping patients get the medications they need without being buried in paperwork, outdated systems, and administrative delays.John shares how witnessing breakthrough treatments transform children's lives at SickKids Hospital shaped his career and inspired him to focus on improving patient access rather than simply developing new therapies. That experience became the foundation for building businesses that simplify specialty medication access for patients, physicians, insurers, and pharmaceutical companies.The conversation explores why healthcare still relies heavily on manual processes, how digitizing prior authorization can dramatically reduce administrative burden, and why trust, relationships, and patient-first thinking remain essential when introducing innovation into one of the world's most complex industries.John also discusses entrepreneurship in healthcare, balancing innovation with patient safety, the realities of building trust across healthcare systems, and why lasting business success begins with solving meaningful problems.You'll hear about:How a life-changing experience at SickKids Hospital shaped John's entrepreneurial journey Why patient access remains one of healthcare's biggest challenges The hidden barriers preventing patients from receiving specialty medications Why healthcare still relies on outdated administrative systems How digital prior authorization can transform patient care The importance of building trust before driving innovation Why patient-first thinking leads to better business decisions Balancing innovation with patient safety The role technology plays in reducing healthcare administration Building successful healthcare companies by solving real problems Lessons from multiple healthcare exits and entrepreneurial ventures Why relationships matter more than speed in healthcare innovation How healthcare technology can improve outcomes for patients and providers Creating meaningful impact through purpose-driven entrepreneurshipWe talk about:00:00 Introduction to John Leombruno and OkRx02:10 The experience at SickKids that changed John's career forever05:15 Why breakthrough medications still don't guarantee patient access07:00 What a truly patient-centered healthcare system should look like10:20 Why specialty medications are becoming mainstream healthcare11:00 Building OkRx to simplify specialty medication access14:20 Balancing scientific thinking with entrepreneurial leadership16:10 Why trust is healthcare's most valuable currency18:00 How innovation succeeds one relationship at a time21:00 Planting seeds that improve healthcare for future generationsConnect with John:LinkedIn: https://www.linkedin.com/in/john-leombruno-4bb1777/ Website: https://www.okrx.ca/ Connect with Us:LinkedIn: Robin Bailey and Al McDonald Website: Aria Benefits and Life & Legacy Advisory Group

In this episode, Eric Huckins, Chief Growth Officer, Lumicera Health Services, Michael DePaz, Vice President of Supply Chain Specialty Pharmacy, Clarventa, and Jamie Palzkill, Director of Manufacturer Relations & Contracting, Clarventa, discuss rising drug costs, supply chain transparency, and the launch of Clarventa's net-price procurement model. They explore how innovative partnerships can help health systems reduce costs, improve medication access, and create a more sustainable pharmacy ecosystem for patients and providers.This episode is sponsored by Lumicera Health Services and Clarventa.

What does it take to build a health organization that will still be running on a strong digital and AI foundation in five years, ten years, or twenty? In this closing conversation, John Henderson, Vice President and Chief Information and Digital Officer at Rady Children's Health, takes the long view. Drawing on his work leading the digital integration of CHOC into Rady Children's Health, launching private generative AI platforms to support clinical and administrative work, and building an AI-ready data infrastructure that reaches beyond the EHR, John shares what it actually takes to align your organization around a multi-year digital vision. John Henderson, VP and CIO, Rady Children's Health Janae Sharp, Founder, The Sharp Index Subscribe to Digital Health Talks on Apple Podcasts, Spotify, YouTube, or wherever you listen.Learn more about HealthIMPACT Live events, virtual forums, and healthcare leader conversations at healthimpactlive.com.Interested in being a guest, sponsoring, or joining the HealthIMPACT community? Visit healthimpactlive.com/digital-health-talks.

In this episode of ACRO's GCP, Tinaya Gray (Executive Director, Site Engagement & PACE at ICON plc), Jan Hewett (SVP, FDA Regulatory Advisor at Advarra), and Jackie Kent (Independent Advisor) unpack the work of ACRO's dive team on representative, generalizable clinical trial data at the 2025 Innovation Network Gathering. Together, they explore why clinical trial populations still fail to reflect real-world patients, and what's been holding the industry back from meaningful progress.The conversation goes beyond identifying the problem. The group shares how a diverse set of stakeholders were able to align around practical, implementable solutions. They also discuss how industry can pilot new approaches, engage broader stakeholders, and turn promising ideas into standard practice. This episode offers a candid and solutions-oriented look at how to generate clinical data that truly supports better decision-making for all patients.

2026 is the year of a major wave of pharmaceutical patent expirations, with numerous blockbuster drugs – spanning diabetes, immunology, cardiovascular, oncology, and other therapeutic areas – on the verge of losing market exclusivity. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Rebecca Guntern, chief commercial officer at Sandoz, for a conversation on the ‘golden decade' for generics and biosimilars as so many blockbuster drugs come off patent. Guntern discusses why the current wave of blockbuster biologics losing exclusivity is so significant for patient access and healthcare budgets, and the conversation also touches upon policy and regulatory changes still needed in order to unlock the full potential of biosimilars, as well as what should be expected from the next generation of biosimilars. You can listen to episode 263 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.

In this special podcast episode, I. Paul Singh, MD, speaks with Deborah Ristvedt, DO, and Kevin Talbot, MD, regarding the use of iDose TR (Glaukos), a procedural pharmaceutical, as an interventional glaucoma approach. They outline who the optimal patients are for this procedure, how to educate patients about drug delivery technology, and share pearls on reimbursement.

What does it take to make sure innovation, policy, and public health actually work for older adults? Too often, patients and caregivers face a hard path from diagnosis to treatment, shaped by Medicare complexity, out-of-pocket costs, communication gaps, and administrative barriers that get in the way of care.In this episode of Patient Advocacy Voices, host Eric Racine is joined by co-host Katie Oppenheim, Head of US Government Relations at Sanofi, for a conversation with Sue Peschin, President and CEO of the Alliance for Aging Research. Together, they discuss how aging research, Medicare policy, vaccine education, and patient advocacy come together to shape access and outcomes for older adults.Sue shares how the Alliance for Aging Research is working to change the narrative on healthy aging, advance evidence-based policy, and help patients better navigate the system. Drawing both on her leadership experience and her personal perspective as a caregiver, she offers practical insight into the barriers older adults face and what it takes to reduce them.In this episode, you'll hear about:How Medicare benefit design, affordability, and utilization management can affect real patient accessWhy aging research matters for chronic disease, infectious disease, and healthier lives as people ageHow advocacy organizations help translate complex policy changes into useful guidance for patients and familiesWhy vaccine education and trusted communication still matter, especially for older adultsWhat mission-driven leadership looks like during times of policy and public health changeThis episode offers practical lessons for advocacy leaders, policymakers, and anyone working to make the healthcare system easier to navigate for older adults and caregivers.

Automation is changing patient access, but prior authorization still requires more than bots, portals, and percentage-based promises. In this episode, Lindsey Nelson, Product Marketing Director at Infinx, explores why agentic workflows, human expertise, clinical judgment, and operational visibility all matter when organizations are trying to reduce delays, avoid denials, and keep work moving.

We love to hear from our listeners. Send us a message.In episode 129 of Cell & Gene: The Podcast, Host Erin Harris reconnects with Zachary Roberts, M.D., Ph.D., EVP of Research & Development and Chief Medical Officer at Allogene Therapeutics, to explore how allogeneic CAR-T is evolving from a scalability promise into an earlier-line, potentially curative intervention. Their conversation centers on the ALPHA3 trial, where MRD-guided treatment is redefining when and how CAR-T can be deployed, alongside broader implications for diagnostics, patient access, and the shift toward off-the-shelf therapies in community settings.Subscribe to the podcast!Apple  |  Spotify |  YouTubeVisit my website: Cell & GeneConnect with me on LinkedIn

Smoother Schedules Start With Smarter Prior Authorization Lora Pada, VP of Customer Success at Infinx, host a practical conversation with Danelle Newman, Director of Patient Access at OSS Health, on how orthopedic practices can take a smarter approach to prior authorization workflows. The discussion will focus on the real operational grind patient access teams face every day, including payer complexity, manual follow-up, documentation gaps, scheduling pressure, and the challenge of keeping patients moving without overwhelming staff. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Same-day cancellations, delayed procedures, and scheduling disruption can create major strain for orthopedic practices. In this Office Hours Takeover, Lora Pada, VP of Customer Success at Infinx, speaks with Danelle Newman, Director of Patient Access at OSS Health, about the role prior authorization workflows play in keeping schedules moving, reducing preventable delays, and giving patient access teams more breathing room.Brought to you by www.infinx.com

Patty Hayward, General Manager of healthcare and life sciences at Talkdesk, describes how a hybrid model of humans and AI is reshaping healthcare contact centers. Patient access and revenue cycle management are the primary, interconnected challenges for these centers, and modern large-language AI is being used to handle complex scheduling logic. Data analytics helps identify patterns in patient inquiries, predict demand peaks, and move care from reactive to proactive. The expectation is that AI agents will guide patients, becoming a normal and accepted part of healthcare. Patty explains, "I think that the challenge has always been in healthcare that it's difficult to automate things in comparison to other industries. If you call retail, it's very hard to get a human. You're constantly dealing with bots or being deflected to digital front doors versus in healthcare, as much as organizations have tried to push people to the digital apps and MyCharts and different things like that, it's been difficult. And there are good reasons, and there are bad reasons for that."   "When you think about scheduling, scheduling really drives your revenue cycle because if people don't come to your organization, you can't bill them for things, you can't bill their insurance. And so your organization has problems with the revenue cycles. That's why I say they're inextricably linked, and it's very important to solve the access problem in order to solve the revenue cycle problem."  "So, making sure that you match that patient with the right provider, making sure that you have the right requirements around insurance authorization and things like that. And then, of course, letting the patient understand what their burden will be as far as the charges go for that appointment is all part of the dance, so to speak. And that really requires a large language model that can consume and understand that information. You're right, the decision trees weren't going to work as far as an AI piece goes." #Talkdesk #AgenticAI #AIAgents #ArtificialIntelligence #AI  #Automation #CustomerServiceAutomation #ValuebasedCare #VBC #PatientExperience #MemberExperience #CustomerExperience #Providers #Payers #HealthcareAI #PatientExperience #HealthTech #ContactCenters #AIInHealthcare #DigitalTransformation #HealthcareInnovation #PatientAccess #RevenueOptimization #HealthcareLeadership talkdesk.com  Listen to the podcast here

Patty Hayward, General Manager of healthcare and life sciences at Talkdesk, describes how a hybrid model of humans and AI is reshaping healthcare contact centers. Patient access and revenue cycle management are the primary, interconnected challenges for these centers, and modern large-language AI is being used to handle complex scheduling logic. Data analytics helps identify patterns in patient inquiries, predict demand peaks, and move care from reactive to proactive. The expectation is that AI agents will guide patients, becoming a normal and accepted part of healthcare. Patty explains, "I think that the challenge has always been in healthcare that it's difficult to automate things in comparison to other industries. If you call retail, it's very hard to get a human. You're constantly dealing with bots or being deflected to digital front doors versus in healthcare, as much as organizations have tried to push people to the digital apps and MyCharts and different things like that, it's been difficult. And there are good reasons, and there are bad reasons for that."   "When you think about scheduling, scheduling really drives your revenue cycle because if people don't come to your organization, you can't bill them for things, you can't bill their insurance. And so your organization has problems with the revenue cycles. That's why I say they're inextricably linked, and it's very important to solve the access problem in order to solve the revenue cycle problem."  "So, making sure that you match that patient with the right provider, making sure that you have the right requirements around insurance authorization and things like that. And then, of course, letting the patient understand what their burden will be as far as the charges go for that appointment is all part of the dance, so to speak. And that really requires a large language model that can consume and understand that information. You're right, the decision trees weren't going to work as far as an AI piece goes." #Talkdesk #AgenticAI #AIAgents #ArtificialIntelligence #AI  #Automation #CustomerServiceAutomation #ValuebasedCare #VBC #PatientExperience #MemberExperience #CustomerExperience #Providers #Payers #HealthcareAI #PatientExperience #HealthTech #ContactCenters #AIInHealthcare #DigitalTransformation #HealthcareInnovation #PatientAccess #RevenueOptimization #HealthcareLeadership talkdesk.com Download the transcript here

Pharma and tech companies are working more closely together than ever. As proven by the news of Merck and NVidia's new partnership, for example. But while the idea of using AI for drug discovery has been around for a while now, patient access has an awfully long way to catch up to the promise of these new therapies. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Dean Erhardt, founder of D2 Solutions, an end-to-end strategic partner delivering industry-leading consulting and purpose-built technologies to pharma manufacturers, hospitals, pharmacies, payers & PBMs. The conversation focuses on the disconnect between distributions, reimbursements, and patient services, particularly when it comes to speciality medicines, as well as patient access today versus the state of patient access tomorrow, and the benefit or otherwise of price protection guarantees with PBMs, when it comes to new therapies. You can listen to episode 256 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.

In this episode, Charlie Lougheed, CEO and co-founder, Axuall, and James Whitfill, MD, Senior Vice President of Strategic Partnerships and Chief Transformation Officer, HonorHealth, discuss how accurate provider data and AI are reshaping patient access and care delivery. They explore data governance, the risks of poor data quality, and how better infrastructure can improve matching, efficiency, and patient outcomes.This episode is sponsored by Axuall.

Access to care in an ambulatory setting continues to challenge health systems as patient expectations grow, pushing organizations to rethink how patients connect with care. Our host Michelle Lewis joins Tyler Bauer, Senior Vice President of System Ambulatory Operations at University of Chicago Medicine to explore how their team is transforming access through more connected and intuitive processes.  Guest: Tyler Bauer, MA, MBA, LCPC Senior Vice President, System Ambulatory Operations UChicago Medicine   Host: Michelle Lewis Senior Director Programs, Performance Improvement Programs Vizient    Show Notes:  [00:45] Areas of improvement in ambulatory access  [02:16] Biggest pain points for patients: connectedness, personalization, and navigation  [03:51] Creating an omnichannel experience  [04:43] AI tools being brought in to help with access strategy  [06:18] Using ambient listening and other AI tools to make a difference for patients and staff  [08:26] Organizational buy-in and compliance with AI application strategy  [10:31] Advice to other healthcare organizations    Links | Resources: Contacting Knowledge on the Go: picollaboratives@vizientinc.com    Subscribe Today! Apple Podcasts Spotify YouTube Android RSS Feed  

In this episode of Home Health Revealed, Hannah Vale sits down with Alex Hartzman, Vice President of Research & Analytics at the National Alliance for Care at Home and Head of Operations at the Research Institute for Home Care, to discuss the policy, payment, and workforce trends shaping the future of home health. They explore the ongoing pressure from Medicare reimbursement changes, the impact of value-based purchasing and quality metrics, and the growing workforce challenges affecting agencies across the country. The conversation also dives into the increasing demand for home-based care, access-to-care concerns, and why the story of home health is not always reaching policymakers the way it should. If you're a home health leader trying to prepare for the years ahead, this episode offers an inside look at the data, policy conversations, and industry realities that will define the future of care at home. Listeners interested in getting involved in advocacy efforts can learn more through the National Alliance for Care at Home Advocacy Action Center and find details about Alliance membership opportunities on their website. The Alliance DC Advocacy Fly-In will take place September 13–16, and Alliance members will receive registration information directly. Chapters (00:00:03) - Home Health Revealed(00:00:25) - Alex Hartzman on Policy Influence in Home Care(00:01:27) - Top 3 issues facing home health agencies(00:05:30) - What Can an Average Home Health Agency Do to Improve Their Quality Score(00:09:37) - Risk of rehospitalization(00:10:35) - Home Health Agency Executives on Staff turnover(00:14:15) - The value of home health(00:19:49) - Home Health and Hospice: A Conversation

In this episode, Megan Eubanks, MBA, Senior Director of Business Operations for Perioperative and Procedural Services at The University of Kansas Health System, discusses how her team is using AI and advanced analytics to improve operating room utilization, increase surgical volume, and expand patient access to care. She also shares lessons on building resilient perioperative operations through transparency, governance, and data driven decision making.

In this episode, Steve Smith, Assistant Vice President of Enterprise Contact Center and Access at Inova Health System, shares how the organization is leveraging cloud based technology, digital assistants, and AI driven tools to streamline scheduling, improve self service, and enhance both patient and team member experiences.

Part II: How Telehealth is Redefining Clinical Practice and Patient Access Join us for part two of a two-part interview with Dr. Brandon Welch, founder and CEO of doxy.me; a platform that has facilitated over 8 billion minutes of care across 1 million providers in 176 countries. With the administration signing the Consolidated Appropriations Act on February 3, 2026, extending Medicare telehealth flexibilities through December 2027, and patient demand driving unprecedented adoption, virtual care has moved from emergency response to fundamental transformation of clinical practice. Brandon examines how the proliferation of telehealth is reshaping medicine itself: clinical workflows, patient-provider relationships, access equity, and sustainable practice models. Drawing from his book Telehealth Success, he delivers actionable strategies for healthcare leaders navigating the five pillars determining telehealth ROI: patient engagement, clinician efficiency, technology scalability, financial viability, and regulatory compliance in an era where patients expect care everywhere. • Five-pillar framework for achieving sustainable telehealth success across organizations • Financial sustainability models leveraging the two-year Medicare telehealth extension through 2027 • Clinical practice transformation reshaping how medicine is delivered and experienced • Provider success strategies addressing burnout, workflow integration, and practice transformation • Access and equity insights from 176-country, 1 million+ provider implementation Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Part I: How Telehealth is Redefining Clinical Practice and Patient Access Join us for part I of a two-part interview with Dr. Brandon Welch, founder and CEO of doxy.me; a platform that has facilitated over 8 billion minutes of care across 1 million providers in 176 countries. With the administration signing the Consolidated Appropriations Act on February 3, 2026, extending Medicare telehealth flexibilities through December 2027, and patient demand driving unprecedented adoption, virtual care has moved from emergency response to fundamental transformation of clinical practice. Brandon examines how the proliferation of telehealth is reshaping medicine itself: clinical workflows, patient-provider relationships, access equity, and sustainable practice models. Drawing from his book Telehealth Success, he delivers actionable strategies for healthcare leaders navigating the five pillars determining telehealth ROI: patient engagement, clinician efficiency, technology scalability, financial viability, and regulatory compliance in an era where patients expect care everywhere. • Five-pillar framework for achieving sustainable telehealth success across organizations • Financial sustainability models leveraging the two-year Medicare telehealth extension through 2027 • Clinical practice transformation reshaping how medicine is delivered and experienced • Provider success strategies addressing burnout, workflow integration, and practice transformation • Access and equity insights from 176-country, 1 million+ provider implementation Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this episode of Revenue Cycle Optimized, Jennifer Glockzin, Senior Director of Patient Access at Infinx, walks through the real-world prior authorization process from intake to determination and appeals. Her breakdown highlights how disciplined workflows, supported by AI agent automation and coordinated human in-the-loop, protect revenue and reduce preventable denials.

Biopharmaceutical innovation is advancing at an unprecedented pace, yet many patients still face barriers to accessing new medicines. In this episode of Health Matters, John O’Brien, president and CEO of the National Pharmaceutical Council, speaks with Kristin Cahill about why policy, pricing and benefit design are increasingly shaping whether innovation reaches patients. O’Brien shares insights from his career spanning pharmaceutical companies, health plans and government, including his time as a senior drug pricing advisor during the first Trump administration. He explains why prescription drugs remain a focal point in cost debates, what policymakers often misunderstand about value, and how middlemen and misaligned incentives affect what patients pay at the pharmacy counter. The conversation also examines emerging approaches such as direct-to-patient models, most-favored-nation pricing and the early effects of the Inflation Reduction Act, highlighting potential benefits as well as risks to access and future innovation. For healthcare professionals, payers and marketers seeking clarity in a complex policy environment, this episode offers a grounded perspective on how to ensure medical breakthroughs translate into meaningful patient benefit. Listen to the full interview.See omnystudio.com/listener for privacy information.

What if patient access isn't just an operational problem—but a shared organizational belief system?In this episode of All Access Pass, host Chris Profeta, Senior Director of Research and Analytics at the Patient Access Collaborative, sits down with Austin Loomis, AVP of Ambulatory Access and Analytics, Mandy Newman, MAAL, Vice President of Ambulatory Operations, and Catherin Mims, MD, Vice President and Associate Chief Physician Executive for the Ambulatory Practice at OU Health. Together, they unpack a new evolution of the Patient Access Framework: a group-based assessment that captures how access is perceived across an entire organization.With more than 20 leaders—from finance and HR to physician chairs and executive leadership—participating in the assessment, OU Health gained a rare, enterprise-wide view of access. The conversation explores what happens when those perspectives align, where they diverge, and why those gaps often represent the greatest opportunities for system improvement. Along the way, the group reflects on why access blind spots persist, how shared language changes strategy, and what it means to truly measure access as an enterprise responsibility.Tune in to hear how group assessments can surface hidden friction, strengthen cross-departmental alignment, and turn access from a siloed function into a shared organizational priority—covering the evolution of the Patient Access Framework, the rationale behind group scoring, leadership alignment, organizational blind spots, and practical insights for system-level access improvement.Woodcock, E., Profeta, C. A framework for patient access management: consensus from a Delphi panel of US health system leaders. BMC Health Serv Res 25, 524 (2025). https://doi.org/10.1186/s12913-025-12561-8https://link.springer.com/article/10.1186/s12913-025-12561-8

Ambulatory leaders may believe care access problems are solved because their utilization metrics are high. However, these numbers may be hiding demand mismatches at the patient, provider, and clinic level. Discover how examining patient mix, no-shows, and late cancellations can help boost access to care and stop revenue leakage. 

In this episode, Melissa Majerol, Model Lead of the Cell and Gene Therapy Access Model at the Center for Medicare and Medicaid Innovation (CMMI) at CMS, breaks down how the CMMI Access Model program aims to simplify and accelerate patient access to innovative cell and gene therapies, starting with recently approved therapies in Sickle Cell disease. Listen in as we dive into the specifics of this new access model and its current status. Music: ‘Bright New Morning’ by Steven O’Brien – released under CC-BY 4.0. https://www.steven-obrien.net/Show your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

In this episode, Michael sits down with Reid Zeising, CEO of GAIN, the largest revenue cycle management organization specializing in litigated and complex healthcare claims. The conversation pulls back the curtain on how healthcare providers struggle to get paid for services already delivered, and how technology and AI are being used to push back against decades of insurance-driven denial strategies. Reid explains how the insurance industry fundamentally changed in 1994, when Allstate introduced Colossus, a system designed to standardize and often suppress claim payouts in favor of shareholder value. That shift, he argues, still shapes today's reimbursement environment, leaving providers underpaid and patients caught in the middle. Drawing on Michael's background in primary care administration, the discussion highlights a stark reality: many healthcare organizations collect only a fraction of what they bill, even when care is medically necessary and properly delivered. Reid compares this to asking professionals to do full work for partial pay and explains why this model is unsustainable, especially for providers serving uninsured and underinsured populations. The conversation then turns to how GAIN is using AI, predictive analytics, and technology-enabled workflows to reverse that imbalance. By focusing on litigated and complex claims, GAIN helps providers recover fair compensation, improve cash flow, and continue offering care to communities that need it most. Reid also shares why his company intentionally shifted away from higher-margin claim financing toward a service-driven model built around access, transparency, and long-term system impact. Michael and Reid also explore the broader healthcare landscape, including the financial strain on providers, the coming “silver tsunami” of aging patients, and the consequences of tort reform on patient access to care. Reid challenges common insurance-industry narratives around “frivolous lawsuits,” explaining how language and lobbying efforts have been used to restrict legitimate claims and reduce accountability. The episode closes with Reid's advocacy work through Americans for Patient Access and Americans for Responsible Consumer Funding, organizations focused on protecting access to healthcare and helping individuals navigate overwhelming medical and financial challenges. This is a candid, systems-level conversation about healthcare economics, AI-driven disruption, and what it will take to ensure providers get paid and patients get care. https://gainservicing.com/ https://www.linkedin.com/in/reidzeising/  

Ro Wickramasinghe, Vice President and Head of Global Business at Pi Health, identifies fundamental problems plaguing clinical trials, including operational inefficiencies and limited access to trials. Pi Health is addressing these challenges by developing an integrated software platform for clinical trial sponsors, sites, and patients and partnering with community-based cancer treatment centers worldwide.  The company has built a hospital in India to serve as a living laboratory to test and refine its model to democratize access and increase the ethnic diversity of trial participants.  Ro explains, "I think the challenge has always been, from a pharma-biotech perspective, is to find patients, but, from the other perspective, its patients participating in trials and being able to find clinical trials. So a lot of stats get bandied around, but despite many eligible patients, the percentage of eligible patients who actually end up in a clinical trial is really small. It's like 5% to 8%, so not a huge amount. I think that's kind of one problem."  "So we have it in chicken and egg scenario where we as a company develop clinical trial software, but when ultimately the vision for us is for that to really become the standard of care and really make trials more efficient for the clinicians that treat the patients and run the trials for these pharma companies and biotech companies that develop the drugs and sponsor the study."  "But having said that, I think to run lots of studies, what we decided to do was to build our own cancer hospital in India. And the beauty of that is that it is fully vertically integrated at the point of care. So the data gets captured on those patients in FICS, which is the software we've developed and then we can run trials. We have run trials for pharma and biotech at that site using our software. So it was, I guess, one of the quicker ways to test the software in a real-world environment and also getting lots of data on FICS and how it can benefit patients from the point of care to being on trials."  #PiHealth #ClinicalTrials #HealthTech #CancerResearch #Innovation #DigitalHealth #PharmaTech #PatientAccess #MedTech #Healthcare #ClinicalResearch #GlobalHealth #HealthcareInnovation #India Pihealth.ai Download the transcript here

Ro Wickramasinghe, Vice President and Head of Global Business at Pi Health, identifies fundamental problems plaguing clinical trials, including operational inefficiencies and limited access to trials. Pi Health is addressing these challenges by developing an integrated software platform for clinical trial sponsors, sites, and patients and partnering with community-based cancer treatment centers worldwide.  The company has built a hospital in India to serve as a living laboratory to test and refine its model to democratize access and increase the ethnic diversity of trial participants.  Ro explains, "I think the challenge has always been, from a pharma-biotech perspective, is to find patients, but, from the other perspective, its patients participating in trials and being able to find clinical trials. So a lot of stats get bandied around, but despite many eligible patients, the percentage of eligible patients who actually end up in a clinical trial is really small. It's like 5% to 8%, so not a huge amount. I think that's kind of one problem."  "So we have it in chicken and egg scenario where we as a company develop clinical trial software, but when ultimately the vision for us is for that to really become the standard of care and really make trials more efficient for the clinicians that treat the patients and run the trials for these pharma companies and biotech companies that develop the drugs and sponsor the study."  "But having said that, I think to run lots of studies, what we decided to do was to build our own cancer hospital in India. And the beauty of that is that it is fully vertically integrated at the point of care. So the data gets captured on those patients in FICS, which is the software we've developed and then we can run trials. We have run trials for pharma and biotech at that site using our software. So it was, I guess, one of the quicker ways to test the software in a real-world environment and also getting lots of data on FICS and how it can benefit patients from the point of care to being on trials."  #PiHealth #ClinicalTrials #HealthTech #CancerResearch #Innovation #DigitalHealth #PharmaTech #PatientAccess #MedTech #Healthcare #ClinicalResearch #GlobalHealth #HealthcareInnovation #India Pihealth.ai Listen to the podcast here

South Carolina Medical Association (SCMA) immediate past president Mayes DuBose, MD and Vice President of Advocacy and Policy Counsel Holly Pisarik discuss efforts that the association has led in fighting bills that would allow unsupervised practice rights to NPs and PAs after just 2,000 hours of clinical hour experience - and let PAs switch specialties after just 1,000 hours.https://www.scmedical.org/Get the books: Patients at Risk https://www.amazon.com/dp/B08M9YJQR3/Imposter Doctors: https://www.amazon.com/dp/1627344438/PhysiciansForPatientProtection.org

Patient access is often measured by speed—but its true value runs much deeper.In this episode of The All-Access Pass, Elizabeth Woodcock, DrPH, MBA, is joined by Brett Butler, Vice President of Access Services at Baylor Scott & White Health, for a candid conversation about what it really takes to elevate access from a transactional function to a system-level strategy.Together, they explore how governance, relationships, and intentional design can unlock capacity, improve clinician experience, and create more equitable, patient-centered care—even amid financial pressure and constrained supply. Brett shares how Baylor Scott & White is scaling access across a complex, multi-market enterprise, why fragmentation is access's greatest enemy, and how technology can illuminate opportunity rather than promise false fixes.This episode challenges access leaders to ask a different question: not how fast can we schedule, but how might we redesign care to truly meet demand—for patients, clinicians, and the system alike.

Send us a textReferrals are meant to connect patients to the care they need, but in reality, they often become a source of delays, dropped handoffs, and administrative chaos. Between intake complexity, missing information, and outdated processes, too many patients get stuck between diagnosis and treatment. Trey Holterman, Co-Founder and CEO of Tennr joins CareTalk host John Driscoll to discuss why referrals break down so often, what makes intake workflows so hard to fix, and how health systems can improve throughput and access without ripping out the systems they already rely on. 

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Clean, connected data is becoming the foundation for real progress in patient access, affordability, and care delivery. In this episode, Lynne Nowak, Chief Data and Analytics Officer at Surescripts, shares how her team is using data, automation, and emerging technologies to remove friction across the healthcare system. She explains how greater interoperability improves information flow among providers, payers, pharmacies, and patients, especially benefiting underserved populations. Lynne details how her organization evaluates AI by focusing on its real-world impact, utilizing it for high-value tasks such as reviewing complex medical records for prior authorizations and digitizing benefit verification. She also highlights new insights such as “first-fill abandonment” and previews upcoming work in adherence analytics, price transparency, and direct-to-patient capabilities. Tune in and discover how smarter data, automation, and real-time insights are transforming access, adherence, and the patient experience across the care continuum. Resources Connect with and follow Lynne Nowak on LinkedIn. Follow Superscripts on LinkedIn and visit their website!

In this episode of American Potential, host David From talks with Ohio Representative Jennifer Gross, a retired Air Force combat lieutenant colonel and longtime nurse practitioner, about her push to modernize Ohio's outdated healthcare rules. Rep. Gross explains how Ohio's Standard Care Arrangement requirement blocks highly trained nurse practitioners from providing care they're fully certified to deliver—especially harming patients in rural and underserved communities. She walks through why removing this mandate would: Expand access to doctors and nurse practitioners across Ohio Reduce wait times and improve patient choice Lower costs for patients and Medicaid Follow the lead of 27 states and 3 territories that have already done it She also shares how Ohio suspended the rule during COVID with no increase in patient harm, proving the system works without the red tape. Rep. Gross urges Ohioans to contact their legislators and support HB 508, the Better Access to Healthcare Act. A powerful conversation about healthcare freedom, patient choice, and letting professionals practice to the full extent of their training.

In this episode, Dr. Joseph Cacchione, Chief Executive Officer of Jefferson Health, and Alex Pinto, Principal at ECG Management Consultants, discuss how health systems can enhance patient access through standardized scheduling, technology integration, and strong physician engagement while navigating cultural and generational shifts in healthcare delivery.

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Trust is the foundation of data-driven healthcare transformation. In this episode, Ryan Weber, Solutions Consultant at TransUnion, discusses how data innovation is being leveraged to enhance patient access, minimize friction, and ensure equitable care for underserved populations. He explains how TransUnion's non-credit data, including contact, property, and behavioral information, helps healthcare organizations clean, verify, and enrich patient information to enhance outreach and engagement. Ryan shares how AI and automation streamline onboarding, reduce manual entry, and strengthen care continuity. He also highlights the company's focus on inclusive data strategies, regulatory compliance, and ethical data use to maintain trust while improving both financial outcomes and patient satisfaction. Tune in and learn how data intelligence and trust are shaping the next generation of patient-centered healthcare experiences! Resources Connect with and follow Ryan Weber on LinkedIn. Follow TransUnion on LinkedIn and visit their website! Email Ryan directly here.

Congressman Craig Murphy, a practicing physician and member of Congress from North Carolina, shares insights on current legislation and the state of healthcare in America. Congressman Murphy discusses the FBI's investigation into political conspiracies, the challenges facing Medicaid, and the importance of reforming the healthcare system to better serve those in need. He also addresses misinformation surrounding healthcare policies and the need for transparency and accountability in government. Next, former Deputy National Security Adviser Victoria Coates joins to discuss the recent NATO meeting with President Trump, the implications of sending Patriot missiles to Ukraine, and the potential for tougher sanctions on Russia. Victoria shares insights on how these developments could reshape international relations, particularly concerning China and the Middle East. Finally, former Trump lawyer and legal expert John Eastman delves into the decision by the FBI to open a grand conspiracy investigation focusing on alleged misconduct by Democrats over the past decade.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.